Zydus and Pharm Aid Ltd. enter into an exclusive agreement for vaccine technology in Russia
Through this agreement, Zydus gains access to the public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakhstan, Armenia and Kyrgyzstan.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Armenia Health | Belarus Health | Biotechnology | Kazakhstan Health | Kyrgyzstan Health | Pharmaceuticals | Russia Health | Uzbekistan Health | Vaccines